Alzheimer's disease is the most common neurodegenerative disorder, with β-amyloid deposition and pathological tau phosphorylation as hallmark features. We provide antibodies and small-molecule tools spanning Aβ, tau, the secretase axis, and neuroinflammation to support mechanistic, biomarker, and therapeutic research.
Focus areas: amyloid cascade, tau propagation, synaptic loss, glial reactivity, proteostasis, and metabolic/vascular contributions
Commonly used for mechanistic studies; follow your lab SOP, compound datasheets, and ethics approvals.
| Compound | Targets / pathways | Experimental notes |
|---|---|---|
| DAPT | γ-secretase complex (watch Notch-related off-targets) | Blocks Aβ production / studies APP processing; mind Notch-related toxicity in vivo/long runs. |
| LY-411575 | γ-secretase | Potent tool; use tight dose windows and mechanistic controls vs other GSIs. |
| Compound E | γ-secretase | Classic in vitro tool; mind batch solubility and vehicle controls. |
| CHIR99021 | GSK3β (also GSK3α; concentration-dependent) | Common for tau hyperphosphorylation readouts; pair total protein + multi-site phospho antibodies. |
| Rapamycin | mTORC1 (FKBP12–Raptor) | Autophagy/proteostasis studies; chronic dosing may engage mTORC2 feedback. |
| MG132 | Proteasome | UPS-dependent stability of APP/tau fragments; high cytotoxicity—window doses tightly. |
| FK506 (Tacrolimus) | Calcineurin | Occasionally used in synaptic plasticity/phosphatase axes; mind immunosuppression/off-targets. |